Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 14 - CANCER CONTROL › Chapter 10.14.01 - Cancer Registry › Section 10.14.01.02 - Incorporation by Reference

Current through Register Vol. 51, No. 14, July 12, 2024
A. In
				  this chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Assisted living program" has the meaning
				  stated in COMAR
				  10.07.14.02B.
(2) "Cancer registry" means a
				  computerized system to register all cases of reportable human cancer or
				  reportable human central nervous system (CNS) tumors of Maryland residents and
				  nonresidents diagnosed or treated in Maryland.
(3) "Cancer report" means a one-time abstract
				  from one or more of the following documents maintained by a reporting facility,
				  nursing facility, assisted living program, or general hospice care program of
				  each new case of reportable human cancer or CNS tumor diagnosed or treated, and
				  any other case of reportable human cancer or CNS tumor initially diagnosed or
				  treated for time periods as designated by the Secretary:
(a) Medical record;
(b) Pathology report; and
(c) Radiological report.
(4) Case of a Reportable Human CNS Tumor.
(a) "Case of a reportable human CNS tumor"
				  means an identified human tumor, irrespective of histologic type or behavior,
				  occurring as a primary tumor in any of the following sites or subsites with
				  International Classification of Diseases for Oncology, Third Edition (ICD-O-3)
				  topography codes C70.0-C72.9 and C75.1-C75.3:
(i) The brain;
(ii) The meninges;
(iii) The spinal cord;
(iv) The cauda equina;
(v) A cranial nerve;
(vi) The pituitary gland;
(vii) The pineal gland; or
(viii) The craniopharyngeal duct.
(b) "Case of a reportable human
				  CNS tumor" includes all benign and uncertain behavior tumors of the CNS
				  (ICD-iO-CM Codes D18.02, D32.0-D33.9, D35.2-D35.4, D42.0-D43.9, D44.3-D44.5,
				  Q85.00-Q85.09 and D 49.6, and all tumors of the CNS of benign and uncertain
				  behavior with ICD-O-3 codes of "0" or "1"), which includes codes from:
(i) The International Classification of
				  Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); and
(ii) The International Classification of
				  Diseases for Oncology, Third Edition (ICD-O-3).
(5) "Case of reportable human cancer" means
				  the identification of a human cancer from the following list, which includes
				  codes from the International Classification of Diseases, Tenth Revision,
				  Clinical Modification (ICD-10-CM) and the International Classification of
				  Diseases for Oncology, Third Edition (ICD-O-3):
(a) All malignant neoplasms with ICD-10-CM
				  Codes C00-C43.9, C44.00, C44.09, C44.10_, C44.19_, C44.20_, C44.29_, C44.30_,
				  C44.39_, C44.40, C44.49, C44.50_, C44.59_, C44.60_, C44.69_, C44.70_, C44.79_,
				  C44.80, C44.89, C44.90, C44.99, C45._-C96._, or with ICD-O-3 behavior code of
				  "3", including genital skin cancer of the vagina, clitoris, vulva, prepuce,
				  penis, and scrotum and excluding other sites of skin cancer with ICD-O-3
				  topography codes C44.0-C44.9 with one of the following ICD-O-3 histologies:
(i) M-8000-8005 Neoplasms, malignant, not
				  otherwise specified of skin;
(ii)
				  M-8010-8046 Epithelial carcinomas of skin;
(iii) M-8050-8084 Papillary and squamous cell
				  carcinomas of skin (C44.02, C44.12_, C44.22_, C44.32_, C44.42, C44.52_,
				  C44.62_, C44.72_, C44.82, C44.92); or
(iv) M-8090-8110 Basal cell carcinomas
				  (C44.01, C44.11_, C44.21_, C44.31_, C44.41, C44.51_, C44.61_, C44.71_, C44.81,
				  C44.91);
(b) All
				  malignant neoplasms with the following ICD-10-CM codes where ICD-O-3 behavior
				  is "3" and ICD-O-3 histologies are reported except as follows:
(i) If there is evidence of multiple foci,
				  lymph node involvement, or metastasis, C37-Thymoma (M-8580);
(ii) C7A.020-Malignant carcinoid tumor of the
				  appendix (M-8240);
(iii) C54.1-Endometrial stroma, low grade
				  (M-8931);
(iv) If there is evidence
				  of multiple foci, lymph node involvement, or metastasis, D48.1-Stromal Tumor of
				  the digestive system (GIST 8639);
(v) D48.60-Phylloides
				  tumor (M-9020);
(vi) D45-Polycythema (M-9950);
(vii) D47.Z9-Plasmacytoma (M-9731, M-9734);
(viii) D4 7.3-Essential thrombocythemia (M-9962),
				  D46.0, D46.1, D46.20, D46.21, D46A, D46B-Low grade myelodysplastic syndrome
				  lesions (M-9980), D46.22-High grade myelodysplastic syndrome lesions (M-9983),
				  D46.C-Myelodysplastic syndrome with 5q deletion (M-9986), D469-Myelodysplastic
				  syndrome, unspecified (M-9975), D47.1-Myelofibrosis with myeloid metaplasia
				  (primary myelofibrosis) (M-9961), D47.Z1-post-transplant lymphoproliferative
				  disorder (M-9989), C94.40, C94.41, C94.42, D47.9, D47.Z9-lympho and
				  myeloproliferative disease (M-9960, M-9970);
(ix) C88.2-Alpha and
				  gamma heavy chain disease (M-9762) or Franklin disease (M-9763);
(x)
				  C88.0-Waldenstrom macroglobulinemia (M-9761);
(xi)
				  D46.4-Refractory anemia (M-9980); or
(xii)
				  D46.1-Refractory anemia with ringed sideroblasts (M-9982), refractory anemia
				  with excess blasts (M-9983), or refractory anemia with excess blasts in
				  transformation (M-9984);
(c) All cases of carcinoma in situ with
				  ICD-10-CM Codes D00._-D09.9, D47.Z2, D49.511- D49.519, D49.59, D78.31-D78.34,
				  and D89.40-D89.49, or with ICD-O-3 behavior code of "2", including genital skin
				  cancers of the vagina, clitoris, vulva, prepuce, penis, and scrotum and
				  excluding other skin cancers with ICD-O-3 topography codes C44.0_-C44.9_ with
				  one of the following ICD-O-3 histologies:
(i)
				  M-8000-8005 Neoplasms, malignant, not otherwise specified of skin;
(ii) M-8010-8046 Epithelial carcinomas of
				  skin;
(iii) M-8050-8084 Papillary
				  and squamous cell carcinomas of skin; and
(iv) M-8090-8110 Basal cell carcinomas;
				  or
(d) All cases of
				  intraepithelial neoplasia with ICD-O-3 histology code of M-8077/2:
(i) Including squamous intraepithelial
				  neoplasia of the larynx (LIN), vagina (VAIN), vulva (VTN), and anus (AIN)
				  (ICD-10-CM codes D02.0, D07.2, D07.1, and D01.3; and ICD-O-3 topography codes
				  C52, C51, and C21.J; and
(ii)
				  Excluding squamous intraepithelial neoplasia of the cervix (CIN III) and
				  glandular intraepithelial neoplasia of the prostate (PIN) (ICD-10-CM codes
				  D06._ and D07.5; and ICD-O-3 topography codes C53 and C61.9).
(6) "Computerized file"
				  means an electronic data file using software approved for use by the Secretary,
				  containing complete cancer report information transferable to a master
				  electronic database system maintained by the Department.
(7) "Department" means the Department of
				  Health and Mental Hygiene or a designee.
(8) "Freestanding ambulatory care facility"
				  has the meaning stated in Health-General Article, § 19-3 B-01, Annotated
				  Code of Maryland.
(9) "Freestanding
				  laboratory" means a facility, place, establishment, or institution which
				  performs a laboratory examination for a person, authorized by law to request
				  the examination, in connection with the diagnosis of a reportable human cancer
				  or CNS tumor, and is licensed by the State pursuant to COMAR 10.10.03, and:
(a) Not under the administrative control of a
				  hospital; or
(b) Under the
				  administrative control of a hospital for a diagnosis of reportable human cancer
				  or CNS tumor of a nonhospitalized patient.
(10) "General hospice care program" has the
				  meaning stated in COMAR
				  10.07.21.02B.
(11) "Hospital" means a facility
				  which is licensed by the State pursuant to COMAR 10.07.01.
(11-1) "Maryland Cancer Registry Data Use Manual and
					 Procedures" means the document that describes the Maryland cancer registry
					 procedures for release of cancer data and that outlines the procedures to
					 obtain both non-confidential aggregate data and confidential individual-level
					 data.
(12) "Nursing
				  facility" has the meaning stated in COMAR
				  10.07.02.01B.
(13) "Physician" means an
				  individual who:
(a) Practices medicine, as
				  defined in Health Occupations Article, §
												14-101, Annotated
				  Code of Maryland; and
(b) Diagnoses
				  or treats a case of reportable human cancer or a reportable human CNS tumor at
				  a practice located in Maryland.
(14) "Reporting facility" means any of the
				  following:
(a) A hospital, freestanding
				  laboratory, freestanding ambulatory care facility, or therapeutic radiological
				  center; or
(b) A physician who has
				  care of or has diagnosed a case of reportable human cancer or reportable human
				  CNS tumor for a nonhospitalized patient not otherwise reported.
(15) "Secretary" means the
				  Secretary of Health and Mental Hygiene or a designee of the
				  Secretary.
(16) "Therapeutic
				  radiological center" means a facility or institution:
(a) Performing radiological treatment for a
				  person authorized by law to request the treatment in connection with a
				  reportable human cancer or a reportable human CNS tumor; and
(b) Licensed or registered by the State
				  pursuant to COMAR 10.05.03 and not under the administrative control of a
				  hospital.